Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

AMD stock rebounds before the bell after brutal selloff as China supply worries surface

AMD stock rebounds before the bell after brutal selloff as China supply worries surface

AMD shares rose about 4% in premarket trading Friday, rebounding after a two-day slide erased over 20% of its value. The company forecast Q1 revenue near $9.8 billion, about 5% below the previous quarter, and warned Chinese clients of server CPU supply delays. AMD’s stock hovered near $200 after closing at $192.50 Thursday. Uncertainty remains over U.S. export licenses for China-bound AI chips.
Bradesco shares slide as Banco Bradesco maps 2026 growth after Q4 profit

Bradesco shares slide as Banco Bradesco maps 2026 growth after Q4 profit

Bradesco’s preferred shares fell 4.5% to 20.19 reais in Sao Paulo after the bank posted a fourth-quarter recurring net income of 6.5 billion reais and outlined 2026 growth targets. The bank expects loan growth of 8.5%–10.5% and net interest income after provisions of up to 48 billion reais. Investors are watching credit costs and expenses linked to Bradesco’s ongoing restructuring.
CCC Intelligent Solutions stock price whipsaws: premarket bounce follows 13% slide as GM lawsuit surfaces

CCC Intelligent Solutions stock price whipsaws: premarket bounce follows 13% slide as GM lawsuit surfaces

CCC Intelligent Solutions shares rose 1.2% to $5.75 in premarket trading Friday after plunging 12.6% the previous session. Court records show General Motors sued CCC and others in a U.S. design-patent case. CCC also announced expanded access to its estimating software for collision-repair schools following a new workforce study. Quarterly results are due Feb. 24.
Pfizer stock slips before open as TrumpRx discounts debut and FDA priority review adds a catalyst

Pfizer stock slips before open as TrumpRx discounts debut and FDA priority review adds a catalyst

Pfizer shares fell 1.1% to $26.49 in premarket trading after the TrumpRx discount drug portal launched Thursday, raising concerns over U.S. drug pricing. Pfizer said its TrumpRx program offers discounts of up to 85% on more than 30 medicines. The FDA granted Priority Review for expanding Hympavzi use in younger hemophilia patients, with a decision expected in the second quarter.
BitMine Immersion (BMNR) stock bounces premarket after Thursday rout as ether trades below $2,000

BitMine Immersion (BMNR) stock bounces premarket after Thursday rout as ether trades below $2,000

BitMine Immersion shares rose 8.7% to $18.91 in premarket trading Friday after plunging 14.3% the previous session. Ether dropped nearly 5%, settling near $1,955, while Bitcoin hovered around $67,421. Crypto-linked stocks including Coinbase and Marathon Digital also fell sharply before the open. BitMine holds over 4.2 million ether tokens and plans to launch its MAVAN staking network by Q1 2026.
Stellantis’ $26.5 billion EV reset jolts markets as carmakers rack up $55 billion in rollbacks

Stellantis’ $26.5 billion EV reset jolts markets as carmakers rack up $55 billion in rollbacks

Stellantis reported a €22.2 billion charge tied to a major EV strategy overhaul, sending shares down as much as 30% in Milan on Friday. The company warned of continued cash outflows, suspended its 2026 dividend, and forecast a net loss of up to €21 billion for H2 2025. Management cited weaker EV demand and shifting regulations.
Confluent stock stays pinned below IBM’s $31 bid as vote nears and SEC filing flags lawsuits

Confluent stock stays pinned below IBM’s $31 bid as vote nears and SEC filing flags lawsuits

Confluent shares traded near $30.36 premarket Friday, just below IBM’s $31-per-share cash offer, after the company filed new merger disclosures with the SEC in response to shareholder demand letters and lawsuits. Confluent will report earnings Feb. 11 but will not hold a call or forecast while the IBM deal remains pending. The shareholder vote is set for Feb. 12.
Hims & Hers (HIMS) stock slides premarket as FDA targets “copycat drugs” over $49 Wegovy pill

Hims & Hers (HIMS) stock slides premarket as FDA targets “copycat drugs” over $49 Wegovy pill

Hims & Hers Health shares fell 3.8% to $23.48 in premarket trading Friday after FDA Commissioner Marty Makary warned of a crackdown on “illegal copycat drugs.” The drop followed Hims’ launch of a $49 compounded version of Novo Nordisk’s Wegovy pill. Novo Nordisk said it would pursue legal and regulatory action, calling Hims’ move “illegal mass compounding.” Investors are watching for FDA enforcement and lawsuits ahead of Hims’ Feb. 23 report.
Grab stock edges higher in premarket as lidar deal and fintech rollout land ahead of earnings

Grab stock edges higher in premarket as lidar deal and fintech rollout land ahead of earnings

Grab shares rose 0.7% to $4.18 in premarket trading Friday after Hesai named Grab its exclusive lidar distributor in Southeast Asia. Grab Finance also launched automated credit decisioning across six countries using FICO’s platform. The company reports Q4 and full-year 2025 results after U.S. markets close on Feb. 11.
MARA stock jolts premarket after $87 million bitcoin move puts miners back in the spotlight

MARA stock jolts premarket after $87 million bitcoin move puts miners back in the spotlight

MARA Holdings shares rose about 10% to $7.39 in premarket trading Friday after plunging 18.7% the previous session. Blockchain data showed MARA moved 1,318 bitcoin—worth roughly $87 million—prompting renewed concerns about miner liquidity. Bitcoin hovered near $66,836 early Friday after swinging between $60,000 and $70,000 this week. U.S. jobs and inflation data releases were postponed to next week.
1 7 8 9 10 11 884

Stock Market Today

Nvidia stock jumps nearly 8% as Big Tech AI spending bets lift chipmakers and Dow tops 50,000

Nvidia stock jumps nearly 8% as Big Tech AI spending bets lift chipmakers and Dow tops 50,000

7 February 2026
Nvidia surged 7.8% Friday, leading a chip stock rally that pushed the Dow above 50,000 for the first time. The PHLX semiconductor index gained 5.7% as Advanced Micro Devices rose 8.3% and Broadcom 7.1%. Amazon fell 5.6% after projecting $200 billion in 2026 capital spending. Investors weighed a $600 billion AI infrastructure outlay against sharp losses in software shares.
Glencore share price steadies after Rio Tinto walks away — what to watch next week

Glencore share price steadies after Rio Tinto walks away — what to watch next week

7 February 2026
Glencore shares closed up 0.6% at 478.1 pence Friday, rebounding after a 7% drop following the collapse of merger talks with Rio Tinto. The company is expected to announce the sale of its Kazzinc stake soon and has signed a non-binding agreement with Orion for a potential $9 billion deal in the DRC. Investors await Glencore’s full-year results on Feb. 18 for further guidance.
Go toTop